Experimental and clinical evidence was suggestive of diclofenac to increase insulin release from beta cells by inhibiting ATP-sensitive K-channels, and this provides a rationale for the observed hypoglycemia [26,27]. This evidence concerns the gene INS and Hypoglycemia.